The Impact of Lean Culture: Paul Wall's Reflections on Justin Bieber and Actavis
Paul Wall reflects on the impact of lean-related reports involving Justin Bieber, suggesting that Actavis, the pharmaceutical company, only took notice when the pop star's association with their cough syrup made headlines. In a recent interview with The Art of Dialogue, Paul discussed his own experiences with lean culture, emphasizing the discreet nature of real lean sippers. He highlighted how the situation changed when Bieber's use of Actavis syrup became publicized, prompting Actavis to react due to the influence on a different demographic.
According to Paul, Actavis initially disregarded the recreational use of their product until Bieber's involvement brought negative attention. The company's decision to cease production and sales of the syrup was linked to concerns about unlawful and dangerous consumption, particularly among Bieber's fan base. This move led to the emergence of alternative brands in the lean market, offering similar products with distinct characteristics to differentiate from Actavis.
Despite the controversy surrounding lean consumption, Bieber recently released a surprise album, SWAG sequel, in 2025, sparking speculation about a potential third installment. While fans eagerly await further updates, ComplexCon is set to return to Las Vegas on October 25–26, 2025, featuring a lineup of over 300 brands and live performances by artists like Young Thug, YEAT & Friends, Peso Pluma, Central Cee, and Ken Carson. Secure your tickets for this exciting event now.